Transient elastography: A non-invasive tool for assessing liver fibrosis in HIV/HCV patients

Table 1 Demographic characteristics of the study populations (mean ± SD) n (%)

	HIV (n = 71)	HCV (n = 53)	HIV/HCV (n = 66)
Age (yr)	43.3 ± 10.3a	49.7 ± 12.5	45.6 ± 12.5
Male gender	50 (70)	36 (67.9)	49 (74.2)
BMI (kg/m2)	23.6 ± 3.4a	26.0 ± 3.6	22.8 ± 3.0b
Risk group
Transfusion	-	17 (32.1)	4 (6.1)b
Homosexual men	21 (29.5)	-	1 (1.5)
Intravenous drug use	4 (5.6)	7 (13.2)c	41 (62.1)
Others	-	12 (22.6)	-
Unknown	9 (12.6)	16 (30.2)	8 (12.1)
HCV genotype 3:non3	-	7:46d	20:46
HAART	57 (80.2)	-	60 (90.9)
Alcohol	6 (8.4)	4 (7.5)	5 (7.5)
Diabetes + IFG	2 (2.8)	4 (7.5)e	11 (16.6)

^aP < 0.002,

^bP < 0.0001 vs hepatitis C virus (HCV);

^cP < 0.0001,

^dP < 0.03,

^eP < 0.001 vs human immunodeficiency virus (HIV)/HCV. IFG: Impaired fasting glucose; BMI: Body mass index; HAART: Highly active anti-retroviral therapy.